These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cytogenetic study of the induction mechanism of chromosome-type aberrations by 1-beta-D-arabinofuranosylcytosine.
    Author: Sekizawa K, Suzuki T, Kishi K.
    Journal: Mutat Res; 2007 Jun 01; 619(1-2):1-8. PubMed ID: 17397878.
    Abstract:
    Treatment of human lymphocytes in the G(1) phase with 1-beta-D-arabinofuranosylcytosine (AraC) results in the formation of chromosome-type aberrations, e.g., dicentric or ring chromosomes. Generally, it is accepted that DNA double-strand breaks (DSBs) cause chromosome-type aberrations. However, AraC lacks the functional groups necessary to induce such breaks, suggesting that it does not induce DSBs directly. In this study, we show that induction of DSBs is not mediated by direct action by AraC on DNA. Second, we demonstrate that the induction of DSBs or chromosome-type aberrations by AraC in human lymphocytes is inhibited by cycloheximide (CHM), an inhibitor of protein synthesis. These data suggest that newly synthesized proteins in AraC-treated lymphocytes mediate the induction of the DSBs. Thus, we suggest that AraC-induced endonucleolytic protein(s) in lymphocytes mediate the formation of chromosome-type aberrations.
    [Abstract] [Full Text] [Related] [New Search]